The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personaliz1
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients wi1
A multidisciplinary team of researchers from the Hospital Clínic Barcelona-IDIBAPS-UB, coordinated by Carolina García-Vidal and Pedro Puerta of the H1
The Members’ General Meeting, held to coincide with the Society’s 16th Congress which took place on 24 and 25 November, approved the appointment.
The University of Pennsylvania professor and pioneer in developing cancer therapies using T cells covered the history, current state, and future chal1
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1
Interview with Dr. Manel Juan, head of the Immunology Service
The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug o1
In just a few months, the coronavirus has gone from being completely unknown to being the focus of countless scientific investigations around the wor1
Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Ho1
